News | March 24, 2026
Bayer wins world-first nod in Japan for low-dose MRI contrast agent
Call it a major breakthrough for diagnostic imaging
Call it a major breakthrough for diagnostic imaging
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
MRI is particularly valuable in pediatric care due to its non-invasive nature
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
It is intended for contrast enhancement in MRI scans
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
He holds a Master’s in Management from the National University of Singapore
Both the products are Gadolinium based Magnetic Resonance Imaging (MRI) contrast agents and will be the first set of contrast agent products in Zydus’ injectable portfolio for the US market
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Subscribe To Our Newsletter & Stay Updated
